Clinical Trial Update: A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating oral AB1010 in adults with moderate to severe chronic plaque psoriasis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AB1010 (AB1010)

Snippet

Sponsor: AB Science | Conditions: Psoriasis | Phase 2 | Status: COMPLETED